$GOOS

Canada Goose loses bull as El Niño, U.S. tariff problems heat up

Wells Fargo analyst Ike Boruchow downgraded Canada Goose to underweight, citing warm weather, European weakness, and U.S.-Canada trade issues. He cut the price target to $10 from $16. Over a third of analysts now recommend selling shares. The stock is down 37% this year, with 88% drop from its 2018 peak, reflecting disappointing earnings and concerns about year-round business prospects.

Original reporting
Published Sep 1, 2026, 11:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 1, 2026, 11:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Canada Goose loses bull as El Niño, U.S. tariff problems heat up — source image
Decision brief

The 30-second read

$GOOSBearishMed
01

Why it matters

The downgrade reinforces bearish sentiment and may trigger short‑covering or further selling pressure.

02

Market read

The downgrade adds to a negative narrative for discretionary apparel, potentially influencing related stocks and sector ETFs.

03

What to watch

Potential cost‑saving initiatives or diversification into year‑round products could mitigate the downside.

Relevance 5/10Novelty 5/10Timing: today

Background

Canada Goose, a premium outerwear brand, has seen a 37% YTD decline and $9 billion market‑cap loss amid weak earnings and macro headwinds.

Company-level read

Ticker impact

$GOOSBearishMedium confidence
Context

Wells Fargo analyst downgraded Canada Goose to underweight and cut the price target to $10 from $16, citing El Niño weather risk and U.S. tariff issues.

Expected impact

Potential further decline of 5‑10% over the next weeks.

Evidence & confidence

Analyst downgrade with a 37% YTD drop already in place; weather and trade headwinds add material risk.

Market effects

Outerwear and luxury apparel sector may face broader pressure from adverse weather patterns and trade tensions.

North American consumer discretionary sentiment could weaken as tariffs and climate risk affect demand.

Highlights macro risk factors that could influence other apparel exporters with similar exposure.

Counterpoint

If El Niño impact is overstated, the stock may be oversold and could rebound on any positive weather outlook.

Key entities

  • Canada Goose Holdings Inc.

    Premium outerwear manufacturer listed on NYSE (GOOS).

  • Wells Fargo & Co.

    Equity research firm issuing the downgrade.

Related articles

$GOOSHigh

Why is Canada Goose stock sliding today?

Canada Goose (GOOS) shares fell 5.5% in pre-market trading after Wells Fargo downgraded the stock to 'underweight' with a C$10.00 price target, citing structural concerns. The stock has faced pressure from multiple analyst downgrades and potential U.S. tariffs on Canadian apparel. The broader market's decline also contributed to the drop, with GOOS trading near its 52-week low of $8.42.

$GOOSMed

Canada Goose Narrows Quarterly Loss Amid Revenue Gains

Updated at 4:24 p.m. July 30. Canada Goose increased revenues and reduced losses last quarter, a sign the company’s multiyear drive to widen its luxury assortment and tighten cost controls is working. For the first quarter ended June 28, total revenue increased 10.3 percent to $118.9 million from $107.8 million, up 8.6 percent on a constant currency basis. All figures are expressed in Canadian dollars, except for per share prices, which are in U.S. dollars.

$GOOSMedAI 8/10

Canada Goose Reports First Quarter Fiscal 2027 Results

Canada Goose Holdings Inc. (GOOS) reported first quarter fiscal 2027 revenue of C$118.9m, up 10.3% year over year. Adjusted EBIT margin improved to (87.3)% from (98.7)%, with operating loss narrowing to $(103.8)m. DTC comparable sales fell 3.2% while e-commerce rose double digits. Inventory turns rose 11% to 1.0x; net debt increased to C$627.8m. Outlook: low-single-digit revenue growth and adjusted EBIT margin 11% to 12%.

$GOOSMedAI 8/10

Why is Canada Goose stock sliding today? By Investing.com

Investing.com reports Canada Goose (GOOS) fell 1.3% in pre-open after Williams Trading downgraded the stock from Hold to Sell and cut its price target to C$10 from C$12. The firm cited a proposed 50% U.S. tariff on Canadian apparel effective Aug. 19, 2026, warning it could force Canada Goose to reduce or withdraw FY27 guidance.

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.